Forms and Documents
- Molecular confirmation of a clinical diagnosis.
- To assist with decisions regarding treatment and management of individuals with congenital myasthenia.
- Testing of at-risk relatives for specific known pathogenic variant(s) previously identified in an affected family
- Prenatal diagnosis for known familial pathogenic variant(s) in at-risk pregnancies.